Patent · US Active

Influenza vaccine formulation

US7807173B2 · kind B2 · utility

0Cited by

0References

11Claims

0Family size

Assignee

Variation Biotechnologies Inc. · CA

Inventor

Andrei Ogrel · Russell, CA

Key dates

Filing date	Nov 30, 2007
Grant date	Oct 5, 2010
Priority date	—
Expiry date	Nov 30, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16134
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Peptide-based anti-influenza formulations against influenza are disclosed. The peptides are derived from influenza-based epitopes. The formulations are based on peptide mixtures which may be formulated so that variability is present at particular residues. The formulations can be used to prepare vaccines for preventing influenza, particularly avian influenza.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.